Skip to content

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07182240
Enrollment
60
Registered
2025-09-19
Start date
2025-12-22
Completion date
2027-06-22
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma

Brief summary

To assess the feasibility and provide information on the utility of noninvasive line field confocal optical coherence tomography (LC-OCT) for the presurgical assessment of Mohs micrographic surgery sites in patients undergoing removal of cutaneous basal cell carcinomas (BCC).

Interventions

DEVICELC-OCT Imaging

handheld imaging device will take high resolution images of lesion

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Participant must understand the investigational nature of this study and provide written consent prior to receiving any study-related procedure. * Participant must be clinically eligible for Mohs surgery as determined by their referring dermatologist and the Mohs surgeon. * The participant must have a BCC with superficial histology or a BCC with multiple histological features that also include superficial histology, which is appropriate for Mohs surgery.

Exclusion criteria

* Known or reported allergy to mineral oil, the optical agent used during imaging. * Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements. * . Any condition which in the investigator's opinion deems the subject an unsuitable candidate to undergo imaging procedure. * Unwilling or unable to follow protocol requirements

Design outcomes

Primary

MeasureTime frameDescription
Number of cases with fully evaluable images1.5 yearscases were the image evaluator can assess the margins based on image quality

Secondary

MeasureTime frameDescription
Patient interest in study1.5 yearsWill be measured by documenting the number of patients offered study participation and the number choosing to participate in the study
Patients overall experienceone office visit - immediately after imaging procedureCollect a 3-question questionnaire to document patients experience.
Determine LC-OCT imaging's impact on surgical workflowTo be filled out immediately after finishing Mohs procedureWill be assessed by results of imaging assessment questionnaire given to surgeon
Accuracy of LC-OCT findings1.5 yearsWill be evaluated by Comparing LC-OCT findings with frozen section histopathological results
Accuracy of LC-OCT in detectng location of tumor1.5 yearswill be evaluated by comparing the location of the LC-OCT reported margin positivity to the Mohs map

Countries

United States

Contacts

CONTACTAsk RPCI
askrpc@Roswellpark.org1-800-767-9355
PRINCIPAL_INVESTIGATORGyorgy Paragh, MD

Roswell Park

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026